Seres Therapeutics Inc. (MCRB)
0.78
0.01 (1.79%)
At close: Jan 15, 2025, 3:59 PM
0.80
1.79%
After-hours Jan 15, 2025, 06:22 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -113.72M | -250.16M | -65.58M | -89.13M | -70.28M | -98.94M | -89.38M | -91.58M | -54.78M | -16.71M | -6.10M | -3.13M |
| Depreciation & Amortization | 6.24M | 6.63M | 5.95M | 6.58M | 7.60M | 7.86M | 7.26M | 4.21M | 728.00K | 190.00K | 88.00K | 25.00K |
| Stock-Based Compensation | 34.10M | 25.48M | 20.22M | 8.82M | 8.34M | 16.64M | 17.36M | 16.86M | 9.69M | 2.07M | 209.00K | 28.00K |
| Other Working Capital | -9.08M | -20.59M | -4.36M | -11.56M | -17.52M | 12.15M | -9.70M | 111.24M | 458.00K | 1.47M | 176.00K | 45.00K |
| Other Non-Cash Items | 15.00M | 7.62M | 2.04M | 3.31M | 2.34M | -214.00K | -213.00K | -386.00K | 367.00K | 398.00K | 19.00K | 28.00K |
| Deferred Income Tax | n/a | n/a | 2.53M | n/a | 103.00K | n/a | n/a | n/a | 7.00K | 1.42M | 8.00K | -28.00K |
| Change in Working Capital | -58.98M | -18.39M | 41.53M | -23.20M | -24.63M | 11.80M | -10.55M | 114.82M | 3.14M | 2.28M | 457.00K | 148.00K |
| Operating Cash Flow | -117.35M | -228.82M | 6.69M | -93.61M | -76.52M | -62.85M | -75.52M | 43.92M | -40.84M | -10.36M | -5.32M | -2.92M |
| Capital Expenditures | -7.97M | -9.82M | -9.57M | -591.00K | -1.00M | -1.94M | -4.68M | -21.49M | -4.36M | -1.00M | -174.00K | -292.00K |
| Acquisitions | n/a | -92.25M | -73.65M | 19.90M | 29.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -4.43M | -48.22M | -95.97M | -218.28M | -46.42M | -21.83M | -96.53M | -290.59M | -267.76M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 22.98M | 140.47M | 169.63M | 59.98M | 16.90M | 136.09M | 158.31M | 246.49M | 136.39M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 92.25M | 73.65M | -19.90M | -29.52M | 114.25M | -113.00K | 139.00K | -1.40M | -102.00K | -10.00K | -27.00K |
| Investing Cash Flow | 10.58M | 82.43M | 64.09M | -158.89M | -30.52M | 112.32M | 56.99M | -65.45M | -137.13M | -1.10M | -184.00K | -319.00K |
| Debt Repayment | 50.52M | 25.70M | -948.00K | 19.90M | 25.00M | n/a | n/a | n/a | -2.60M | 1.60M | 944.00K | 500.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -197.00K | -33.00K | n/a | -24.00K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 3.03M | 2.73M | 2.13M | 14.88M | 16.00K | 404.00K | 116.00K | 2.14M | -2.69M | 122.39M | n/a | 8.93M |
| Financial Cash Flow | 71.70M | 129.60M | 1.18M | 303.42M | 86.23M | 268.00K | 83.00K | 2.14M | 137.72M | 123.99M | 944.00K | 9.44M |
| Net Cash Flow | -35.06M | -16.79M | 71.95M | 50.92M | -20.81M | 49.73M | -18.45M | -19.39M | -40.25M | 112.53M | -4.56M | 6.19M |
| Free Cash Flow | -125.33M | -238.64M | -2.88M | -94.20M | -77.52M | -64.79M | -80.20M | 22.43M | -45.21M | -11.36M | -5.50M | -3.22M |